<p>Brazilian company Precisa Medicamentos, representing India's Bharat Biotech, on Monday, said it requested that the country's health regulator, Anvisa, grant emergency authorization to use the Covaxin Covid-19 vaccine.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus" target="_blank"><strong>CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</strong></a></p>.<p>In addition, it said Covaxin would be trialled in a Phase III study in Brazil carried out in partnership with Sao Paulo's Albert Einstein hospital. </p>
<p>Brazilian company Precisa Medicamentos, representing India's Bharat Biotech, on Monday, said it requested that the country's health regulator, Anvisa, grant emergency authorization to use the Covaxin Covid-19 vaccine.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus" target="_blank"><strong>CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</strong></a></p>.<p>In addition, it said Covaxin would be trialled in a Phase III study in Brazil carried out in partnership with Sao Paulo's Albert Einstein hospital. </p>